Cargando…

RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer

Androgen receptor (AR) signaling is essential for the development of prostate cancer. Here, we report that runt-related transcription factor (RUNX1) could be a key molecule for the androgen-dependence of prostate cancer. We found RUNX1 is a target of AR and regulated positively by androgen. Our RUNX...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takayama, Ken-ichi, Suzuki, Takashi, Tsutsumi, Shuichi, Fujimura, Tetsuya, Urano, Tomohiko, Takahashi, Satoru, Homma, Yukio, Aburatani, Hiroyuki, Inoue, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385850/ https://www.ncbi.nlm.nih.gov/pubmed/25537508

Ejemplares similares

Androgen‐induced lncRNA POTEF‐AS1 regulates apoptosis‐related pathway to facilitate cell survival in prostate cancer cells
por: Misawa, Aya, et al.
Publicado: (2017)

A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor
por: Yamada, Yuta, et al.
Publicado: (2016)

Clinical Significance of Amyloid Precursor Protein in Patients with Testicular Germ Cell Tumor
por: Yamada, Yuta, et al.
Publicado: (2013)

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial
por: Fujimura, Tetsuya, et al.
Publicado: (2015)

Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors
por: Takayama, Ken-ichi, et al.
Publicado: (2020)

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018)

Androgen‐responsive tripartite motif 36 enhances tumor‐suppressive effect by regulating apoptosis‐related pathway in prostate cancer
por: Kimura, Naoki, et al.
Publicado: (2018)

Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor
por: Yamada, Yuta, et al.
Publicado: (2016)

CLDN8, an androgen‐regulated gene, promotes prostate cancer cell proliferation and migration
por: Ashikari, Daisaku, et al.
Publicado: (2017)

ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells
por: Migita, Toshiro, et al.
Publicado: (2017)

Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth
por: Obinata, Daisuke, et al.
Publicado: (2014)

Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression
por: Takayama, Ken-ichi, et al.
Publicado: (2017)

Runx transcription factors in neuronal development
por: Inoue, Ken-ichi, et al.
Publicado: (2008)

Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer
por: Taguchi, Satoru, et al.
Publicado: (2014)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
por: Claessens, Frank, et al.
Publicado: (2008)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Ribonuclease H2 Subunit A Preserves Genomic Integrity and Promotes Prostate Cancer Progression
por: Kimura, Naoki, et al.
Publicado: (2022)

Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling
por: Takayama, Ken-ichi
Publicado: (2019)

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
por: Sato, Yuzuri Tsurumaki, et al.
Publicado: (2014)

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2
por: Labaf, Maryam, et al.
Publicado: (2022)

Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity
por: Hornig, N. C., et al.
Publicado: (2016)

Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer
por: Oshima, Masashi, et al.
Publicado: (2023)

A cryptic transactivation domain of EZH2 binds AR and AR’s splice variant, promoting oncogene activation and tumorous transformation
por: Wang, Jun, et al.
Publicado: (2022)

The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer
por: Kodach, Liudmila L., et al.
Publicado: (2010)

RUNX3 mediates keloid fibroblast proliferation through deacetylation of EZH2 by SIRT1
por: Liu, Hanye, et al.
Publicado: (2022)

Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2017)

CircRUNX2 through has‐miR‐203 regulates RUNX2 to prevent osteoporosis
por: Yin, Qudong, et al.
Publicado: (2018)

Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
por: Sugiura, Masahiro, et al.
Publicado: (2020)

Elevated expression of RUNX3 co-expressing with EZH2 in esophageal cancer patients from India
por: Rehman, Asad Ur, et al.
Publicado: (2020)

Inhibition of EZH2 ameliorates bacteria-induced liver injury by repressing RUNX1 in dendritic cells
por: Wang, Yanan, et al.
Publicado: (2020)

Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer
por: Takayama, Ken-ichi, et al.
Publicado: (2021)

Androgen receptor (AR) antagonism triggers acute succinate‐mediated adaptive responses to reactivate AR signaling
por: Saxena, Neetu, et al.
Publicado: (2021)

KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC
por: Wang, Hung-Jung, et al.
Publicado: (2018)

RUNX3 Has an Oncogenic Role in Head and Neck Cancer
por: Tsunematsu, Takaaki, et al.
Publicado: (2009)

Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction
por: Xu, Defeng, et al.
Publicado: (2017)

Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications
por: Zhao, Pei, et al.
Publicado: (2019)

Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino‐terminal domain
por: Hua, Yaping, et al.
Publicado: (2018)

Immunohistochemical Expression of Androgen Receptors (AR) in Various Breast Cancer Subtypes
por: Ismael, Nour El Hoda S., et al.
Publicado: (2019)

Regulation of androgen receptor splice variant AR3 by PCGEM1
por: Zhang, Ziqiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e1u6obuejk57ab1vi1af9mgpge